X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs MYLAN (US) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   MYLAN
EQUITY SHARE DATA
    NOVARTIS
Mar-18
MYLAN
Dec-18
NOVARTIS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs7583,284-   
Low Rs5791,808-   
Sales per share (Unadj.) Rs228.41,511.3-  
Earnings per share (Unadj.) Rs31.741.0-  
Cash flow per share (Unadj.) Rs32.8324.0-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs297.11,634.9-  
Shares outstanding (eoy) m24.69514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.7 173.7%   
Avg P/E ratio x21.162.0 33.9%  
P/CF ratio (eoy) x20.47.9 259.7%  
Price / Book Value ratio x2.21.6 144.5%  
Dividend payout %31.50-   
Avg Mkt Cap Rs m16,5051,309,968 1.3%   
No. of employees `0000.735.0 1.9%   
Total wages/salary Rs m1,4450-   
Avg. sales/employee Rs Th8,441.322,216.0 38.0%   
Avg. wages/employee Rs Th2,163.60-   
Avg. net profit/employee Rs Th1,173.1603.3 194.5%   
INCOME DATA
Net Sales Rs m5,639777,561 0.7%  
Other income Rs m1,7180-   
Total revenues Rs m7,357777,561 0.9%   
Gross profit Rs m-63201,204 -0.0%  
Depreciation Rs m25145,590 0.0%   
Interest Rs m5537,398 0.1%   
Profit before tax Rs m1,57518,216 8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m792-2,898 -27.3%   
Profit after tax Rs m78421,114 3.7%  
Gross profit margin %-1.125.9 -4.3%  
Effective tax rate %50.3-15.9 -315.9%   
Net profit margin %13.92.7 511.8%  
BALANCE SHEET DATA
Current assets Rs m9,522434,189 2.2%   
Current liabilities Rs m3,296316,572 1.0%   
Net working cap to sales %110.415.1 729.9%  
Current ratio x2.91.4 210.6%  
Inventory Days Days3784 43.8%  
Debtors Days Days2893 30.5%  
Net fixed assets Rs m46150,834 0.0%   
Share capital Rs m123414 29.8%   
"Free" reserves Rs m7,2130-   
Net worth Rs m7,336841,179 0.9%   
Long term debt Rs m0907,902 0.0%   
Total assets Rs m11,1052,256,369 0.5%  
Interest coverage x29.51.5 1,982.7%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.50.3 147.3%   
Return on assets %7.62.6 291.3%  
Return on equity %10.72.5 425.5%  
Return on capital %22.23.2 699.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,5700-   
CASH FLOW
From Operations Rs m1,610161,577 1.0%  
From Investments Rs m687-83,518 -0.8%  
From Financial Activity Rs m-2,677-75,272 3.6%  
Net Cashflow Rs m-3801,339 -28.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69 Rs / USD

Compare NOVARTIS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: AJANTA PHARMA  SUVEN LIFESCIENCES  PANACEA BIOTECH  VENUS REMEDIES  AUROBINDO PHARMA  



Today's Market

Sensex Opens in Green; HDFC Bank and Yes Bank Top Gainers(09:30 am)

Asian share markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 1.2% while the Hang Seng is up 1%.

Related Views On News

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock (Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend (The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Driverless Cars are Here. And This Tiny Company is in the Lead... (The 5 Minute Wrapup)

Jul 17, 2019

This future-ready company thrives on the pace of technological change.

Here's Why This Smallcap Will Beat the Big Autos in the EV Race (Profit Hunter)

Jul 16, 2019

As the conventional auto sector faces existential crisis, my latest smallcap recommendation is all set to ride the electric vehicle disruption and rise in new age vehicles.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 24, 2019 11:51 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS